EUVIMED · CrossrefZeitschrift
BJC Reports
ISSN 2731-9377 · Springer Science and Business Media LLC
Neueste Artikel
Cabozantinib with or without immune checkpoint inhibition in heavily pretreated patients with advanced sarcoma
Human papillomavirus 16 genomic variation in head and neck cancer: a systematic review with structural and functional annotation
Homologous recombination deficiency (HRD) testing of high-grade serous carcinoma using cytological samples
Molecular subtypes and the (in vitro) response of glioblastoma to temozolomide
Disparities in blood cancer survival in the UK 2009–2019: national cohort studies
Cancer care disparities among patients with limited English proficiency: challenges and strategies for equity
Attenuation of malignant phenotype of glioblastoma following a short course of the pro-oxidant combination of Resveratrol and Copper
Circulating tumor DNA monitoring detects minimal residual disease and predicts outcomes in patients with esophageal adenocarcinoma or squamous cell carcinoma after esophagectomy
Patient derived cancer-associated fibroblasts from non-small cell lung cancer undergo phenotypic drift in culture
B cells and tertiary lymphoid structures in cancer therapy response
Increasing incidence of early-onset kidney cancer in young adults aged
Increasing use of artificial intelligence in genomic medicine for cancer care- the promise and potential pitfalls
A phase Ia study of the MEK1/2 inhibitor PD-0325901 with the c-MET inhibitor crizotinib in patients with advanced solid cancers
Predictive biomarkers for the efficacy of PARP inhibitors in ovarian cancer: an updated systematic review
Deep-learning enabled combined measurement of tumour cell density and tumour infiltrating lymphocyte density as a prognostic biomarker in colorectal cancer
CITRINO: phase 1 dose escalation study of anti-LAG-3 antibody encelimab alone or in combination with anti-PD-1 dostarlimab in patients with advanced/metastatic solid tumours
Efficacy and safety of sacituzumab govitecan Trop-2-targeted antibody-drug conjugate in solid tumors and UGT1A1*28 polymorphism: a systematic review and meta-analysis
Therapeutic vulnerabilities and pan-cancer landscape of BRAF class III mutations in epithelial solid tumors
Head and neck cancer incidence is rising but the sociodemographic profile is unchanging: a population epidemiological study (2001–2020)
Small extracellular vesicles as biomarkers of response in recurrent/metastatic HNSCC patients treated with immunotherapy
Cannabidiol and fluorinated derivative anti-cancer properties against glioblastoma multiforme cell lines, and synergy with imidazotetrazine agents
Predictive model of castration resistance in advanced prostate cancer by machine learning using genetic and clinical data: KYUCOG-1401-A study
System transferability of Raman-based oesophageal tissue classification using modern machine learning to support multi-centre clinical diagnostics
Accuracy of ultrasound, magnetic resonance imaging and intraoperative frozen section in the diagnosis of ovarian tumours: data from a London tertiary centre
Phase II trial of pembrolizumab, ipilimumab, and aspirin in melanoma: clinical outcomes and translational predictors of response
Real-world effectiveness of CDK 4/6 inhibitors in estrogen-positive metastatic breast cancer
New light on chemotherapy toxicity and its prevention
The natural history of neurolymphomatosis
Exploring the prognostic impact of absolute lymphocyte count in patients treated with immune-checkpoint inhibitors
Protein prognostic biomarkers in stage II colorectal cancer: implications for post-operative management
EUVIMED